These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 29642855

  • 21. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q, Zhang P, Ma Y, Lu Z, Meng J, Li H, Wang X, Chen D, Zhang M, Han Y, Liu H, Ma S.
    Gene; 2018 Apr 30; 652():48-58. PubMed ID: 29427737
    [Abstract] [Full Text] [Related]

  • 22. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C, Qin Y, Zhi Q, Wang J, Qin C.
    Int J Biol Macromol; 2018 Feb 30; 107(Pt B):2620-2629. PubMed ID: 29080815
    [Abstract] [Full Text] [Related]

  • 23. Atractylenolide II reverses the influence of lncRNA XIST/miR-30a-5p/ROR1 axis on chemo-resistance of colorectal cancer cells.
    Zhang R, Wang Z, Yu Q, Shen J, He W, Zhou D, Yu Q, Fan J, Gao S, Duan L.
    J Cell Mol Med; 2019 May 30; 23(5):3151-3165. PubMed ID: 30907503
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.
    Huang K, Chen J, Yang MS, Tang YJ, Pan F.
    Cancer Biomark; 2017 May 30; 18(3):231-239. PubMed ID: 28085008
    [Abstract] [Full Text] [Related]

  • 25. MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy.
    Cai Y, An B, Yao D, Zhou H, Zhu J.
    Bioengineered; 2021 Dec 30; 12(2):10713-10722. PubMed ID: 34747309
    [Abstract] [Full Text] [Related]

  • 26. LncRNA NORAD/miR-202-5p regulates the drug resistance of A549/DDP to cisplatin by targeting P-gp.
    Shen JG, Xu SN, Yin LG.
    Gen Physiol Biophys; 2020 Sep 30; 39(5):481-489. PubMed ID: 33084601
    [Abstract] [Full Text] [Related]

  • 27. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y, Fei Z, Zhu R.
    Anticancer Drugs; 2020 Apr 30; 31(4):385-393. PubMed ID: 31913198
    [Abstract] [Full Text] [Related]

  • 28. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer.
    Wu K, Hu Y, Yan K, Qi Y, Zhang C, Zhu D, Liu D, Zhao S.
    J Cell Physiol; 2020 Feb 30; 235(2):1247-1258. PubMed ID: 31267531
    [Abstract] [Full Text] [Related]

  • 29. Exosome-transmitted miR-769-5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53.
    Jing X, Xie M, Ding K, Xu T, Fang Y, Ma P, Shu Y.
    Clin Transl Med; 2022 May 30; 12(5):e780. PubMed ID: 35522909
    [Abstract] [Full Text] [Related]

  • 30. MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2.
    Liu R, Guo H, Lu S.
    Cancer Med; 2018 Sep 30; 7(9):4598-4609. PubMed ID: 30019389
    [Abstract] [Full Text] [Related]

  • 31. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
    Wang J, Jia J, Zhou L.
    Neoplasma; 2020 Nov 30; 67(6):1279-1292. PubMed ID: 32787433
    [Abstract] [Full Text] [Related]

  • 32. CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity.
    Xu Y, Jiang T, Wu C, Zhang Y.
    Biotechnol Lett; 2020 Jul 30; 42(7):1123-1135. PubMed ID: 32170433
    [Abstract] [Full Text] [Related]

  • 33. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X, Chen Y, Shen Y, Tantai J.
    Cell Death Dis; 2019 Jun 03; 10(6):429. PubMed ID: 31160576
    [Abstract] [Full Text] [Related]

  • 34. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
    Rao C, Miao X, Zhao G, Zhang C, Shen H, Dong C, Yang M.
    Biomed Pharmacother; 2019 Jun 03; 114():108662. PubMed ID: 30999114
    [Abstract] [Full Text] [Related]

  • 35. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y, Jiang J, Jia H, Qiao Z, Zhang J.
    Cell Physiol Biochem; 2018 Jun 03; 51(1):129-141. PubMed ID: 30439707
    [Abstract] [Full Text] [Related]

  • 36. MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway.
    Wang X, Zhao H, Wang P, Zhang J, Li N, Liu Y, Zhang F, Yu Y.
    Anticancer Drugs; 2022 Nov 01; 33(10):989-998. PubMed ID: 36206129
    [Abstract] [Full Text] [Related]

  • 37. Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.
    Kim JH, Ahn JH, Lee M.
    Cancer Res Treat; 2017 Oct 01; 49(4):947-959. PubMed ID: 28052651
    [Abstract] [Full Text] [Related]

  • 38. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
    Liu X, Zhou X, Chen Y, Huang Y, He J, Luo H.
    Neoplasma; 2020 Jan 01; 67(1):147-157. PubMed ID: 31686523
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1.
    Pei K, Zhu JJ, Wang CE, Xie QL, Guo JY.
    Eur Rev Med Pharmacol Sci; 2016 Nov 01; 20(22):4697-4704. PubMed ID: 27906433
    [Abstract] [Full Text] [Related]

  • 40. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X, Dong J, He X, Shen L, Long C, Liu F, Liu X, Lin T, He D, Wei G.
    Biomed Pharmacother; 2020 May 01; 125():109880. PubMed ID: 32004974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.